医学
第九
肺癌分期
肺癌
医学物理学
放射科
TNM分期系统
登台系统
肿瘤分期
阶段(地层学)
癌症
肿瘤科
内科学
古生物学
物理
纵隔镜检查
生物
声学
作者
Maximiliano Klug,Zehavit E. Kirshenboim,Mylene T. Truong,Vera Sorin,Efrat Ofek,Rishi Agrawal,Edith Michelle Marom
出处
期刊:Radiographics
[Radiological Society of North America]
日期:2024-11-14
卷期号:44 (12): e240057-e240057
被引量:31
摘要
Lung cancer continues to be the primary cause of cancer-related deaths globally. Precise staging is imperative for the development of successful treatment approaches and improvement of patient outcomes. Traditionally, lung cancer staging has depended on the TNM staging system, and the International Association for the Study of Lung Cancer (IASLC) has recently recommended modifications. The updated classification for the ninth edition of the TNM staging system (TNM-9), slated to take effect in January 2025, is derived from a thorough analysis of a newly established large international database of lung cancer cases compiled by the IASLC. Proposed changes in TNM-9 include the following: (a) The mediastinal nodal category (N2) was split into single-station (N2a) and multiple-station (N2b) subcategories, and (b) multiple extrathoracic metastatic lesions (M1c) were split into single organ system (M1c1) and multiple organ systems (M1c2) subcategories. Considering these revisions, adjustments have been made to the established stage groups. In terms of pathologic nodal staging, patients in the post-neoadjuvant ypN category demonstrated worse prognosis than those in the similar non-neoadjuvant pN category. Understanding the fundamental changes introduced in TNM-9 enables radiologists to precisely determine the clinical stage of lung cancer and enhance therapeutic approaches.
科研通智能强力驱动
Strongly Powered by AbleSci AI